FDA Approves New Indication for Eli Lilly’s Cialis

by Kathy Jones on  October 7, 2011 at 8:11 PM Drug News
RSS Email Print This Page Comment
The US Food and Drug Administration announced that it has approved Eli Lilly's tadalafil tablets to be used in treating erectile dysfunction and benign prostatic hyperplasia or BPH, a condition in which the prostate gland is enlarged and may lead to urinary symptoms.
 FDA Approves New Indication for Eli Lilly’s Cialis
FDA Approves New Indication for Eli Lilly’s Cialis
Advertisement

The tablets, which will be sold under the brandname Cialis, will now be used for treating erectile dysfunction and signs and symptoms of BPH separately. Additionally, it will also be used to treat patients who have ED along with the signs and symptoms of BPH.

Advertisement
The approval comes following clinical trials which showed that the drug was better than placebo in treating patients with ED and ED plus BPH.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive